Wei Yue
About
Wei Yue is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Infectious Diseases.
According to data from OpenAlex, Wei Yue has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 11 papers in Pediatrics, Perinatology and Child Health and 9 papers in Infectious Diseases. Recurrent topics in Wei Yue's work include Drug Transport and Resistance Mechanisms (23 papers), Pharmacological Effects and Toxicity Studies (11 papers) and HIV/AIDS drug development and treatment (9 papers). Wei Yue is often cited by papers focused on Drug Transport and Resistance Mechanisms (23 papers), Pharmacological Effects and Toxicity Studies (11 papers) and HIV/AIDS drug development and treatment (9 papers). Wei Yue collaborates with scholars based in United States, United Kingdom and Germany. Wei Yue's co-authors include Alexandra Crowe, Kim L. R. Brouwer, Khondoker Alam, Kai Ding, Joseph S. Pagano, Sonia Pahwa, Koji Abe, Edward Gershburg, Arlene S. Bridges and Lang Li and has published in prestigious journals such as PLoS ONE, Journal of Virology and International Journal of Molecular Sciences.
In The Last Decade
Wei Yue
27 papers receiving 1.1k citations
Hit Papers
Peers
Wei Yue
Leslie W. Chinn United States
Ursula Ehmer Germany
Tian Lan China
Ping He China
Alexandra Crowe United States
Hae‐Yun Jung South Korea
Paulo Rodrigues‐Santos Portugal
Yueming Qian United States
Carlo Vascotto Italy
Laura Cesaratto Italy
Citations per year, relative to Wei Yue Wei Yue (= 1×)
peers
Leslie W. Chinn
Countries citing papers authored by Wei Yue
Since
Specialization
Citations
This map shows the geographic impact of Wei Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Yue more than expected).
Fields of papers citing papers by Wei Yue
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Wei Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Yue. The network helps show where Wei Yue may publish in the future.
Co-authorship network of co-authors of Wei Yue
This figure shows the co-authorship network connecting the top 25 collaborators of Wei Yue. A scholar is included among the top collaborators of Wei Yue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Yue. Wei Yue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Tambe, Vishakha, et al.. (2024). Regulation of organic anion transporting polypeptide 1B1 transport function by concurrent phosphorylation and lysine-acetylation: A novel posttranslational regulation mechanism. Molecular Pharmacology. 107(2). 100007–100007.
2.
Tambe, Vishakha, et al.. (2023). Differential Preincubation Effects of Nicardipine on OATP1B1- and OATP1B3-Mediated Transport in the Presence and Absence of Protein: Implications in Assessing OATP1B1- and OATP1B3-Mediated Drug–Drug Interactions. Pharmaceutics. 15(3). 1020–1020.
3.
Alam, Khondoker, et al.. (2023). Assessing Trans-Inhibition of OATP1B1 and OATP1B3 by Calcineurin and/or PPIase Inhibitors and Global Identification of OATP1B1/3-Associated Proteins. Pharmaceutics. 16(1). 63–63.
4.
Brouwer, Kim L. R., Raymond Evers, Shuiying Hu, et al.. (2022). Regulation of Drug Transport Proteins—From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium. Clinical Pharmacology & Therapeutics. 112(3). 461–484.
5.
Pahwa, Sonia, et al.. (2021). Pre-incubation with OATP1B1 and OATP1B3 inhibitors potentiates inhibitory effects in physiologically relevant sandwich-cultured primary human hepatocytes. European Journal of Pharmaceutical Sciences. 165. 105951–105951.
6.
Xu, Chao, et al.. (2021). Development of a Rat Sandwich-Cultured Hepatocytes Model Expressing Functional Human Organic Anion Transporting Polypeptide (OATP) 1B3: A Potential Screening Tool for Liver-Targeting Compounds. Journal of Pharmacy & Pharmaceutical Sciences. 24. 475–483.
7.
Crowe, Alexandra, Qiang Liu, Sonia Pahwa, et al.. (2020). Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interaction Potential of Vemurafenib Using R-Value and Physiologically-Based Pharmacokinetic Models. Journal of Pharmaceutical Sciences. 110(1). 314–324.
8.
Crowe, Alexandra & Wei Yue. (2019). Semi-quantitative Determination of Protein Expression Using Immunohistochemistry Staining and Analysis: An Integrated Protocol. BIO-PROTOCOL. 9(24).
9.
Crowe, Alexandra, Oliver Hatley, Sibylle Neuhoff, et al.. (2019). Preincubation With Everolimus and Sirolimus Reduces Organic Anion-Transporting Polypeptide (OATP)1B1- and 1B3-Mediated Transport Independently of mTOR Kinase Inhibition: Implication in Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions. Journal of Pharmaceutical Sciences. 108(10). 3443–3456.
10.
Alam, Khondoker, Alexandra Crowe, Pengyue Zhang, et al.. (2018). Regulation of Organic Anion Transporting Polypeptides (OATP) 1B1- and OATP1B3-Mediated Transport: An Updated Review in the Context of OATP-Mediated Drug-Drug Interactions. PMC.
11.
Li, Yingchao, Yongjun Wang, Ran Zhang, et al.. (2018). Improving the oral bioavailability of tapentadol via a carbamate prodrug approach: synthesis, bioactivation, and pharmacokinetics. Drug Delivery and Translational Research. 8(5). 1335–1344.
12.
Alam, Khondoker, et al.. (2018). Characterization of Liver- and Cancer-type-Organic Anion Transporting Polypeptide (OATP) 1B3 Messenger RNA Expression in Normal and Cancerous Human Tissues. Drug Metabolism Letters. 12(1). 24–32.
13.
Alam, Khondoker, et al.. (2017). Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner. PLoS ONE. 12(11). e0186924–e0186924.
14.
Pahwa, Sonia, Khondoker Alam, Alexandra Crowe, et al.. (2017). Pretreatment With Rifampicin and Tyrosine Kinase Inhibitor Dasatinib Potentiates the Inhibitory Effects Toward OATP1B1- and OATP1B3-Mediated Transport. Journal of Pharmaceutical Sciences. 106(8). 2123–2135.
15.
Powell, John, Kathleen Köck, Xiaojie Meng, et al.. (2014). Novel Mechanism of Impaired Function of Organic Anion-Transporting Polypeptide 1B3 in Human Hepatocytes: Post-Translational Regulation of OATP1B3 by Protein Kinase C Activation. Drug Metabolism and Disposition. 42(11). 1964–1970.
16.
Claire, Robert L. St., et al.. (2011). Differential Disposition of Chenodeoxycholic Acid versus Taurocholic Acid in Response to Acute Troglitazone Exposure in Rat Hepatocytes. Toxicological Sciences. 120(2). 371–380.
17.
Yue, Wei, et al.. (2011). PU.1-dependent regulation of UCH L1 expression in B-lymphoma cells. Leukemia & lymphoma. 52(7). 1336–1347.
18.
Swift, Brandon, Wei Yue, & Kim L. R. Brouwer. (2010). Evaluation of 99mTechnetium-Mebrofenin and 99mTechnetium-Sestamibi as Specific Probes for Hepatic Transport Protein Function in Rat and Human Hepatocytes. Pharmaceutical Research. 27(9). 1987–1998.
19.
Yue, Wei, Jin Kyung Lee, Koji Abe, Yuichi Sugiyama, & Kim L. R. Brouwer. (2010). Decreased Hepatic Breast Cancer Resistance Protein Expression and Function in Multidrug Resistance-Associated Protein 2-Deficient (TR−) Rats. Drug Metabolism and Disposition. 39(3). 441–447.
20.
Yue, Wei, Kōji Abe, & Kim L. R. Brouwer. (2008). Knocking Down Breast Cancer Resistance Protein (Bcrp) by Adenoviral Vector-Mediated RNA Interference (RNAi) in Sandwich-Cultured Rat Hepatocytes: A Novel Tool To Assess the Contribution of Bcrp to Drug Biliary Excretion. Molecular Pharmaceutics. 6(1). 134–143.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Leslie W. Chinn Breakdown of academic impact, for papers by Ursula Ehmer Breakdown of academic impact, for papers by Tian Lan Breakdown of academic impact, for papers by Ping He Breakdown of academic impact, for papers by Alexandra Crowe Breakdown of academic impact, for papers by Hae‐Yun Jung Breakdown of academic impact, for papers by Paulo Rodrigues‐Santos Breakdown of academic impact, for papers by Yueming Qian Breakdown of academic impact, for papers by Carlo Vascotto Breakdown of academic impact, for papers by Laura Cesaratto